Life Insurance for Diabetics in Texas: A1C Thresholds, Type 1 vs Type 2, and Best Carriers
'/%3e%3cstop%20offset='1'%20stop-color='hsl(217%2091%25%2045%25)'/%3e%3c/linearGradient%3e%3c/defs%3e%3crect%20width='96'%20height='96'%20rx='48'%20fill='url(%23bg)'/%3e%3ccircle%20cx='48'%20cy='38'%20r='16'%20fill='white'%20fill-opacity='0.95'/%3e%3cpath%20d='M18%2084c0-16%2013.4-28%2030-28s30%2012%2030%2028v12H18z'%20fill='white'%20fill-opacity='0.95'/%3e%3c/svg%3e){kind=small}
Diabetics can qualify for life insurance in Texas, but pricing depends on type, age of onset, A1C control, and comorbidities. Well-controlled Type 2 diabetes diagnosed after age 50 with A1C under 7.0 and no complications often reaches Standard Plus rates at the best carriers. Type 1 diabetes typically caps at Standard or Table 2–4 (roughly 150–200% of standard premium) regardless of control. Gestational diabetes that fully resolves postpartum usually does not affect rates at all after a two-year clean interval.
How underwriters read diabetes
Diabetes underwriting turns on four data points: type (1 vs 2), age at diagnosis, most recent A1C reading, and complications (retinopathy, neuropathy, nephropathy, cardiovascular disease). A Texas broker's medical questionnaire captures all four before submission, and getting them right on the first pass often makes a full rating class of difference. For the broader evidence file carriers pull, see our Texas life insurance underwriting guide.
A1C is the dominant signal. Carriers group applicants into rough bands: under 6.5 (excellent control), 6.5–7.0 (good), 7.0–7.9 (acceptable), 8.0–8.9 (elevated), and 9.0+ (poor). The band, combined with the type and complication profile, drives the rate class offered.
Type 2 diabetes: the most common case
Type 2 accounts for roughly 90–95% of adult diabetes diagnoses. A Texas applicant diagnosed with Type 2 after age 50, treated with metformin only, with an A1C under 7.0 and no complications, typically qualifies for Standard Plus or Standard rates at Prudential, Lincoln National, or John Hancock. That is roughly 105–125% of preferred-plus premium — not the best rate class, but well within reasonable range.
Younger diagnoses (before age 40) are treated more conservatively because the exposure period is longer. A 35-year-old Type 2 diabetic often lands at Table 2–4 (150–200% of standard) even with excellent control, because the actuarial risk of long-term complications is higher.
Insulin-dependent Type 2 diabetics typically lose one rate class relative to oral-medication controlled peers. GLP-1 agonists (Ozempic, Mounjaro) and SGLT-2 inhibitors are viewed neutrally by most carriers, though a few are still catching up.
Type 1 diabetes: still insurable, always rated
Type 1 (juvenile-onset, autoimmune) is treated differently because the exposure window covers the entire adult life. Most carriers cap Type 1 applicants at Standard or Table 2–4 regardless of A1C control, insulin pump usage, or continuous glucose monitor (CGM) data.
The most Type 1-friendly carriers in Texas in 2026 are Prudential, Lincoln National, and Symetra. Prudential in particular has an aggressive Type 1 program that will consider Standard rates for applicants diagnosed after age 30 with A1C under 7.5 and no complications.
For younger Type 1 applicants (diagnosis before age 20), the practical ceiling is Table 4 (roughly 200% of standard premium). Guaranteed-issue whole life is always available as a fallback for anyone unable to qualify for fully underwritten coverage.
Gestational diabetes: usually a non-issue
Gestational diabetes that fully resolves postpartum, confirmed by a normal post-pregnancy A1C, typically does not affect rate class at all after a 12–24 month clean interval. Carriers will ask about it on the application and want to see the postpartum lab result, but the rating impact is normally zero.
The exception is when gestational diabetes progresses into Type 2 diabetes within a few years — a known elevated risk for women who experienced gestational cases. In that scenario the rating follows Type 2 rules based on current A1C and treatment.
Complications that change the math
Any documented diabetic retinopathy, neuropathy, or nephropathy typically moves the applicant down at least two rate classes. Diabetic nephropathy with elevated creatinine or reduced eGFR is the most impactful complication and often triggers a decline for fully underwritten term at reasonable ratings.
Cardiovascular disease combined with diabetes (the classic 'diabetic heart' presentation) is treated as a compound impairment. Prior heart attack or coronary stent placement adds another 3–5 tables of rating on top of the diabetic base rate.
Applicants with any of these complications should focus on carriers with dedicated impaired-risk programs — Prudential, John Hancock, Legal & General America — rather than the standard-carrier top-tier that will decline aggressively.
How to prepare a diabetic application in Texas
Pull the last 24 months of A1C readings from your endocrinologist or primary care provider before applying. Carriers will request an attending physician statement (APS) and want to see a downward trend or stable control, not just a single good reading.
If the most recent A1C is high, delay the application 60–120 days while working with your physician to improve control. A single good reading immediately preceding underwriting is often enough to shift a rate class by one full table, saving 25–50% on lifetime premium.
Work with an independent broker who can shop the case blind across carriers with dedicated diabetic programs before generating any formal application. A single decline lands on your MIB record for seven years and can trigger cascading declines at other carriers. Well-controlled applicants may also qualify for accelerated underwriting with no paramed exam.
FAQ
Under 6.5 is optimal — carriers consider that excellent control and typically offer their best available rate class for a diabetic applicant. Under 7.0 is still strong and usually qualifies for Standard Plus at the most flexible carriers. Above 8.0 typically means Table 2–4 rating or higher.
Not directly. Carriers rely on the A1C lab result and the physician's notes from your endocrinologist visits, which typically summarize CGM data in the medical record. If your CGM data shows unusually good control that is not reflected in the A1C, ask your physician to note it in the chart before the APS is pulled.
Yes. Insulin use typically costs one rate class relative to oral-medication controlled peers, but does not disqualify an applicant. Type 1 diabetics on insulin can still reach Standard rates at the most flexible carriers with good control.
Yes. A Type 2 diagnosis before age 40 is treated more conservatively because the exposure window is longer. Expect Table 2–4 ratings even with excellent A1C control, versus Standard or Standard Plus for a diagnosis after age 50 with the same control.
If it improves your A1C, absolutely — a demonstrable A1C improvement and BMI drop over a 6-month period can shift you a full rate class, saving substantial lifetime premium. Applications submitted mid-transition often benefit from a 60-120 day delay to let the labs catch up.
Sources & further reading
Primary statutory, regulatory, and tax references for the claims in this article. Specific premium quotes and carrier underwriting thresholds are illustrative — confirm with a current quote and the carrier's published guide.
- National Diabetes Statistics Report — Centers for Disease Control and Prevention
- Standards of Care in Diabetes — American Diabetes Association
- Texas Insurance Code §1131.104 (Incontestability) — Texas Statutes
- Request Your MIB Consumer File — MIB Group
- Life Insurance — Consumer Information — Texas Department of Insurance
Want this modeled for your situation?
Twenty-minute call, written recommendation, no hard sell.
Book a free consultKeep reading